Person:
KENİŞ COŞKUN, ÖZGE

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

KENİŞ COŞKUN

First Name

ÖZGE

Name

Filters

2015 - 20182
Reset filters

Settings

End date: 2019 × Subject: Coccygodynia ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    PublicationOpen Access
    Pain Relief due to Transsacrococcygeal Ganglion Impar Block in Chronic Coccygodynia: A Pilot Study
    (OXFORD UNIV PRESS, 2015-07) GÜNDÜZ, OSMAN HAKAN; Gunduz, Osman Hakan; Sencan, Savas; Kenis-Coskun, Ozge
    ObjectiveCoccygodynia is a distressing condition that presents with pain around the coccyx. Impar (Walther) ganglion is a sympathetic ganglion located at the end of lumbosacral sympathetic chain. The objective of this study is to share our results and follow up of 34 ganglion impar blocks in 22 patients. DesignRetrospective pilot study. SettingInterventional Pain Clinic in the Department of Physical Medicine and Rehabilitation in a university hospital. SubjectsTwenty-two patients with coccygodynia who did not respond to conservative treatment and then presented to interventional pain clinic of a PM&R department in a university hospital MethodsPain was evaluated via 10-cm visual analog scale (VAS). VAS values were obtained before, 1 hour and 3 weeks after injection and during this study was conducted. ResultsFor achieving at least 50% relief of pain, the success rate of a first injection was 82%, but accounted for three technical failures. In patients with a successful outcome, relief lasted for a median duration of 6 months. Relief was reinstated for a median period of 17 months by a second injection in nine patients who presented for repeat treatment. No relief was achieved in two of these patients when they presented for a third treatment. ConclusionsGanglion impar block appears to be effective in patients who have coccygodynia resistant to conservative therapy, with high success rates and prolonged duration of effect. Controlled studies are required to reveal the mechanism of this effect.
  • No Thumbnail Available
    PublicationMetadata only
    Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report
    (ELSEVIER URBAN & PARTNER SP Z O O, 2018) GÜNDÜZ, OSMAN HAKAN; Sencan, Savas; Kenis-Coskun, Ozge; Demir, Fatma Gul Ulku; Cuce, Isa; Ercalik, Tulay; Gunduz, Osman Hakan
    Aim of the study: To define the effectiveness of ganglion Impar block in improving neuropathic pain. Materials and methods: Patients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients' painless sitting duration was also recorded. Results: A total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients' improved significantly. Conclusions: Ganglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear. (C) 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.